Finland: Faron tops up working capital with private placement
Faron Pharmaceuticals, a Finland-based clinical stage biopharmaceutical company harnessing the immune system to tackle cancer and inflammation, has completed a private placement of 2,006,621...
Belgium: Aedifica raises €254.5m in private placement of shares
Brussels listed specialist healthcare real estate investor, Aedifica, has raised €254,475,000 (US$269,315,982) through a private placement to international institutional investors. The capital increase was...
Funding round-up: AiVF, Axbio, Aidoc, LynxCare, 3Z
Iceland: 3Z, a drug discovery company, has closed a US$2m funding round led by seasoned investors in pharmaceuticals and medical technology. The Reykjavik based company...
Luxembourg: Eurofins prices Eurobond as hybrids approach call dates
Eurofins Scientific, the global leader in bio-analysis, has priced a €600m (US$634m) seven-year senior unsecured bond to repurchase outstanding notes. The Baa3/ BBB (Moody’s/Fitch)...
KSA: Nabaa Al-Heha Medical Services gets go-ahead to IPO
Nabaa Al Seha Medical Services has received approval from the Saudi Capital Market Authority to register and offer 1.4 million shares representing 20% of...
South Korea: Lunit files registration statement with Korean Exchange for IPO
Lunit, a leading provider of AI solutions for cancer, has filed a registration statement with the Korean Exchange for an IPO of its common...
France: Orpea makes first drawdown from syndicated loan package
Euronext Paris-listed, Orpea, one of the world leaders in dependency care, has announced the first drawdown of €250m (US$262m) from its core banking pool...
Sweden: Aqilion issue in kind marks final instalment of Regulus acquisition from LEO Pharma
Aqilion, a biotech company that focuses on developing new treatments for diseases caused by chronic inflammation and dysfunctional immune reactions, has resolved on an...
Funding round-up: Nowatch, Amili, TILT Biotherapeutics, Lead Pharma and Oxeltis, META Pharmaceuticals
China: META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A funding rounds totalling US$15m. Investors include Forcefield Ventures, XtalPi, IMO Ventures,...
CareTech navigates challenges with international and digital performing well
CareTech navigated through the various challenges presented by Covid-19, staff shortages and inflationary pressures, posting slight revenue growth, while EBITDA remained flat.
Its half-year results...
©2023 All rights reserved LaingBuisson 
